Author:
Vaishampayan Ulka N.,Heilbrun Lance,Vaishampayan Nitin,Harper Felicity W.K.,Shi Dongping,Smith Daryn,Green Kelly,Guru Khurshid,Li Qiang,Kuettel Michael,Chatta Gurkamal,Maier Jordan,Dickow Brenda,Moore Tanina Foster,George Saby
Funder
National Institutes of Health
Bristol-Myers Squibb
Karmanos Cancer Center
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference18 articles.
1. American Cancer Society. Cancer facts & figures 2022. Accessed February 15, 2023. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html
2. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy;Galsky;Lancet Oncol,2011
3. Treatment of patients with metastatic urothelial cancer “unfit” for cisplatin-based chemotherapy;Galsky;J Clin Oncol,2011
4. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: A pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233;Mak;J Clin Oncol,2014
5. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer;James;N Engl J Med,2012